WallStreetZenWallStreetZen

NASDAQ: FBIO
Fortress Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FBIO

Based on 1 analyst offering 12 month price targets for Fortress Biotech Inc

Min Forecast
$17.00+378.87%
Avg Forecast
$17.00+378.87%
Max Forecast
$17.00+378.87%

Should I buy or sell FBIO stock?

Based on 1 analyst offering ratings for Fortress Biotech Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although FBIO's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates FBIO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their FBIO stock forecasts and price targets.

FBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-21

1 of 1

Forecast return on equity

Is FBIO forecast to generate an efficient return?

Company
N/A
Industry
131.35%
Market
-50.97%

Forecast return on assets

Is FBIO forecast to generate an efficient return on assets?

Company
N/A
Industry
47.84%

FBIO earnings per share forecast

What is FBIO's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.24
Avg 2 year Forecast
-$1.47
Avg 3 year Forecast
-$1.97

FBIO revenue forecast

What is FBIO's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$92.9M+56.62%
Avg 2 year Forecast
$128.8M+117.17%
Avg 3 year Forecast
$145.3M+145.02%
FBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FBIO revenue growth forecast

How is FBIO forecast to perform vs Biotechnology companies and vs the US market?

Company
36.51%
Industry
85.89%
Market
10.84%
FBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FBIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FBIO$3.55$17.00+378.87%Buy
ATOS$0.82$6.17+653.91%Buy
SPRO$1.88N/AN/A
ACHV$3.04$12.00+294.74%Buy
HLVX$2.10$2.00-4.76%Hold
View Top Biotech Stocks

Fortress Biotech Stock Forecast FAQ

Is Fortress Biotech Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: FBIO) stock is to Buy FBIO stock.

Out of 1 analyst, 0 (0%) are recommending FBIO as a Strong Buy, 1 (100%) are recommending FBIO as a Buy, 0 (0%) are recommending FBIO as a Hold, 0 (0%) are recommending FBIO as a Sell, and 0 (0%) are recommending FBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Fortress Biotech stock.

What is FBIO's earnings growth forecast for 2025-2027?

(NASDAQ: FBIO) Fortress Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.27%.

Fortress Biotech's earnings in 2025 is -$24,052,000.On average, 2 Wall Street analysts forecast FBIO's earnings for 2025 to be -$36,895,894, with the lowest FBIO earnings forecast at -$38,681,179, and the highest FBIO earnings forecast at -$35,110,609. On average, 2 Wall Street analysts forecast FBIO's earnings for 2026 to be -$43,739,487, with the lowest FBIO earnings forecast at -$75,577,073, and the highest FBIO earnings forecast at -$11,901,901.

In 2027, FBIO is forecast to generate -$58,616,863 in earnings, with the lowest earnings forecast at -$58,616,863 and the highest earnings forecast at -$58,616,863.

What is FBIO's revenue growth forecast for 2025-2027?

(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 36.51% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 85.89%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Fortress Biotech's revenue in 2025 is $59,301,000.On average, 2 Wall Street analysts forecast FBIO's revenue for 2025 to be $2,763,621,459, with the lowest FBIO revenue forecast at $2,401,208,567, and the highest FBIO revenue forecast at $3,126,034,350. On average, 2 Wall Street analysts forecast FBIO's revenue for 2026 to be $3,831,965,865, with the lowest FBIO revenue forecast at $3,296,826,632, and the highest FBIO revenue forecast at $4,367,105,098.

In 2027, FBIO is forecast to generate $4,323,365,611 in revenue, with the lowest revenue forecast at $4,323,365,611 and the highest revenue forecast at $4,323,365,611.

What is FBIO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: FBIO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 47.84%.

What is FBIO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year FBIO price target, the average FBIO price target is $17.00, with the highest FBIO stock price forecast at $17.00 and the lowest FBIO stock price forecast at $17.00.

The Wall Street analyst predicted that Fortress Biotech's share price could reach $17.00 by Aug 21, 2026. The average Fortress Biotech stock price prediction forecasts a potential upside of 378.87% from the current FBIO share price of $3.55.

What is FBIO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FBIO) Fortress Biotech's current Earnings Per Share (EPS) is -$1.00. On average, analysts forecast that FBIO's EPS will be -$1.24 for 2025, with the lowest EPS forecast at -$1.30, and the highest EPS forecast at -$1.18. On average, analysts forecast that FBIO's EPS will be -$1.47 for 2026, with the lowest EPS forecast at -$2.54, and the highest EPS forecast at -$0.40. In 2027, FBIO's EPS is forecast to hit -$1.97 (min: -$1.97, max: -$1.97).

What is FBIO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: FBIO) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.